The Pancreatic Cancer Therapy Program at the University of Maryland Greenebaum Cancer Center offers a highly specialized, multidisciplinary approach to the evaluation, diagnosis and treatment of patients with pancreatic cancer.
Our team consists of specialists who are nationally recognized experts in pancreas cancer and lead scientific efforts to develop new and more effective therapies that are offering hope to more and more patients each year. They meet weekly to review each patient's case and develop the best possible treatment plan.
Our Pancreatic Cancer Therapy Program provides:
Our patients receive the most comprehensive and effective treatment available anywhere.
We place a high priority on providing patients with immediate access to our nationally renowned pancreas cancer specialists. To see a surgical oncology specialist for a consultation within two business days, please call our Patient Referral Office coordinator at 410-328-7904. (See also: Immediate Access to Cancer Experts.)
Each year, approximately 30,000 people are diagnosed with pancreatic cancer in the United States. Most of these are people over the age of 50 with no family history of the disease. Because its symptoms are not specific and no screening test is currently available, pancreatic cancer is often not diagnosed until it is at a fairly advanced stage. Aggressive treatment, with a combination of surgery to remove all or part of the pancreas followed by radiation and/or chemotherapy, offers the best outcome for patients.